Alternative Treatment for Gonorrhea and Chlamydia with Ceftriaxone Allergy
For patients with severe cephalosporin allergy, treat with azithromycin 2 g orally as a single dose for gonorrhea, PLUS azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days for chlamydia coverage. 1
Treatment Algorithm
For Gonorrhea in Cephalosporin-Allergic Patients:
Primary Alternative Regimen:
- Azithromycin 2 g orally, single dose 1
- This is the CDC-recommended alternative for patients who cannot receive ceftriaxone due to severe cephalosporin allergy
- Critical caveat: This regimen has reduced efficacy compared to ceftriaxone, particularly for pharyngeal infections
- Mandatory test-of-cure at 1 week is required 1
For Chlamydia Co-Treatment:
Since gonorrhea and chlamydia frequently co-exist, you must treat both organisms:
For Chlamydia:
- Azithromycin 1 g orally, single dose (preferred) 2, 3
- OR Doxycycline 100 mg orally twice daily for 7 days 2, 3
- OR Levofloxacin 500 mg orally once daily for 7 days (alternative) 2
Combined Regimen Strategy:
Option 1 (Single-dose approach):
- Azithromycin 2 g orally for gonorrhea (this dose also covers chlamydia) 1
Option 2 (If concerned about GI tolerability of 2g azithromycin):
- Azithromycin 2 g orally for gonorrhea
- PLUS Doxycycline 100 mg orally twice daily for 7 days for additional chlamydia coverage
Important Clinical Considerations
Limitations of Azithromycin 2g:
- Pharyngeal gonorrhea: Significantly less effective than ceftriaxone 1
- Gastrointestinal side effects: Common with 2g dose, causing nausea and diarrhea 4
- Resistance concerns: CDC discourages widespread use due to emerging macrolide resistance 5, 2
- Not first-line: Only use when ceftriaxone truly cannot be given 1
Mandatory Follow-Up:
Test-of-cure is non-negotiable for alternative regimens:
- Perform at 1 week post-treatment 1
- Test at all infected anatomic sites
- Use culture if available, or NAAT if culture unavailable 1
- If NAAT positive, confirm with culture and perform antimicrobial susceptibility testing 1
Site-Specific Efficacy Concerns:
The evidence shows differential efficacy by anatomic site:
- Urogenital infections: Azithromycin 2g has reasonable efficacy 1
- Pharyngeal infections: Substantially reduced efficacy compared to ceftriaxone 1, 6
- Rectal infections: Limited data, but likely reduced efficacy 6
Alternative Options Under Investigation
While not yet standard of care, emerging alternatives include:
- Gentamicin 240 mg IM plus azithromycin 2 g orally: Recommended by some international guidelines for treatment failures, but showed inferior efficacy for pharyngeal/rectal sites in trials 7, 6
- Aztreonam: Small case series suggest efficacy, but limited data 8
- Ertapenem: Shows promise but requires multiple doses 7, 9
- Zoliflodacin: Novel oral agent in late-stage development, but not yet FDA-approved and has reduced pharyngeal efficacy 10, 11
Critical Pitfalls to Avoid
Do not use spectinomycin - It is no longer available in the United States 5, 4
Do not use quinolones (ciprofloxacin, ofloxacin, levofloxacin) for gonorrhea - Widespread resistance makes these ineffective 12
Do not use cefixime as an alternative in cephalosporin allergy - It is also a cephalosporin and carries cross-reactivity risk 1
Do not skip chlamydia coverage - Co-infection rates are high (up to 40-50% in some populations) 13
Do not forget test-of-cure - This is mandatory for all alternative regimens, unlike standard ceftriaxone therapy 1
Special Populations
Pregnancy:
- Azithromycin 2 g is acceptable for gonorrhea 5, 2
- For chlamydia: Use azithromycin 1 g OR amoxicillin 500 mg three times daily for 7 days 2
- Never use doxycycline or quinolones in pregnancy 5, 2
Consultation Recommended: Given the limited data on alternative regimens and concerns about treatment failure, consult an infectious disease specialist when treating cephalosporin-allergic patients with gonorrhea 5, 2. The CDC also offers consultation services at 404-639-8659 1.